Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-16

Clinical Trial Update: ReActiv8 Post Market Surveillance Registry

View source ↗

Summary

The ReActiv8 post-market surveillance registry for chronic low back pain has completed and its results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ReActiv8

Snippet

Sponsor: Mainstay Medical | Conditions: Chronic Low Back Pain | Status: COMPLETED | Results posted: 2024-10-16